Oliver K��nzler leads Wenger Plattner‘s corporate and commercial department, which is capable of implementing M&A transactions under the Swiss Merger Act, as well as possessing considerable knowledge of Swiss-related asset and M&A transactions. Marc S Nater principally advises clients on public and private M&A, private equity and commercial law, while Benjamin Dürig bolsters the practice with his thorough knowledge of M&A and corporate finance transactions.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Oliver Künzler's long experience in combination with his negotiation and language skills - Oliver is fluent in German, English and French - make him a very talented legal advisor on international transactions.'

  • 'I value Oliver Künzler's pragmatism and business focus.'

  • 'They are very professional and solution oriented.'

  • 'Oliver Künzler is a great lawyer, very knowledgeable on M&A matters and always available.'

Key clients

  • Bio-Techne
  • GENUI GMBH
  • EMERAM Capital
  • TRITON Partners
  • VI Partners
  • Stadler Rail Group
  • Sostrene Grene
  • Gradiant
  • Audi AG
  • Novartis Pharma Ltd.
  • Julius Baer Group
  • SIGNA Group
  • Sun Hung Kai & Co. Limited
  • Meta Investments
  • Storskogen
  • Great Point Partners
  • BACHEM
  • OMNES Capital
  • Normet Group OY
  • TX Group AG
  • SWICA Gesundheitsorganisation
  • HRG Hotels GmbH
  • Rivean Capital (formerly Gilde Buy-Out Partners)
  • CIBT, Inc.
  • Hawesko
  • HG Commerciale
  • ADUR Management AG
  • SBI Holdings
  • Capital Transmission SA
  • Magazine zum Globus AG
  • Tonix Pharmaceuticals Inc.
  • Align Technology, Inc.
  • Hospitality Swiss Proco AG
  • GA Europe GmbH
  • Saurer Group
  • Brütsch/Rüegger Gruppe
  • 1337 Holding AG
  • Neovii Pharmaceutical AG
  • Artisa Digital AG
  • Apecx Swiss AG

Work highlights

  • Advised AUDI AG as lead counsel with respect to its entry into Formula 1 as power unit supplier, as well as the takeover of 75% of the shares in an existing Formula 1 team.
  • Acted as lead counsel to US-listed group Bio-Techne on the acquisition of Lunaphore Technologies AG.
  • Advised WSD, a structured products software provider, on all the Swiss legal aspects regarding the acquisition of Solvians.

Practice head

The lawyer(s) leading their teams.

Oliver Künzler